Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536252 ((2S)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 62.8 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536252 ((2S)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 67.8 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536223 ((2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-meth...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 202 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536223 ((2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-meth...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 239 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536223 ((2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-meth...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 304 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536223 ((2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-(4-(4-meth...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 418 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536284 ((5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 418 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536198 (US11242344, Example 104.4) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 422 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536277 (US11242344, Example 1001.2 | US11242344, Example 1...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 795 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536284 ((5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(1-methyl-1H-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 939 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536276 ((5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.62E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536276 ((5S)-2-((4R)-4-hydroxy-1-(3-methyl-2-(3-methyl-1,2...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536254 (US11242344, Example 113.4) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.28E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536254 (US11242344, Example 113.4) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.92E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536250 ((2R)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.94E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536210 (US11242344, Example 106.2 | US11242344, Example 10...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.96E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536268 ((5S)-2-((4R)-4-hydroxy-1-(2-(3-hydroxyisoxazol-5- ...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.35E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536183 (2-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.68E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536240 (1-Cyano-N-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.97E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536240 (1-Cyano-N-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536206 (US11242344, Example 105.4) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536183 (2-((2S)-1-((4R)-4-hydroxy-2-((S)-5-methyl-5-(4-(4-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.48E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536259 (1-((2S,4R)-2-(5,5-dimethyl-1-phenyl-4,5-dihydro-1H...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.67E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536178 (N-((2S)-1-((4R)-4-Hydroxy-2-(5-methyl-5-(4-(4-meth...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.17E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536297 (US11242344, Example 1004.4) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536291 ((5S)-2-((4R)-1-(2-(3-((6-(2-((4-((3-Ethynylphenyl)...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536250 ((2R)-1-((2S,4R)-2-(5-(4-Bromophenyl)-5-methyl-4,5-...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536190 (US11242344, Example 103.4) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.73E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536259 (1-((2S,4R)-2-(5,5-dimethyl-1-phenyl-4,5-dihydro-1H...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.32E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536271 (1-((2S,4R)-2-((R)-5-(2′-fluoro-[1,1′-b...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536215 ((2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-phenyl-4,5...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.07E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536226 (US11242344, Example 108.2) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536231 ((2R)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.62E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536179 ((5S)-2-((4R)-4-hydroxy-1-((S)-1-(methylsulfonyl)pi...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536275 (US11242344, Example 1001.1) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.69E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536215 ((2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-phenyl-4,5...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.73E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536231 ((2R)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.75E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536231 ((2R)-1-((2S,4R)-2-(2,3-dihydro-4'H-spiro[indene-1,...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.76E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536239 ((2R)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthale...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.96E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536239 ((2R)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthale...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.99E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536239 ((2R)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthale...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536232 ((5S)-2-((4R)-4-Hydroxy-1-(3-methyl-2-(1-methyl-1H-...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.06E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536271 (1-((2S,4R)-2-((R)-5-(2′-fluoro-[1,1′-b...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.17E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536251 ((2R)-1-((2S,4R)-2-(5-(4-bromophenyl)-5-(trifluorom...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.26E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536239 ((2R)-1-((4R)-2-(3,4-dihydro-2H,4'H-spiro[naphthale...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536244 ((5S)-2-((4R)-4-hydroxy-1-((methylsulfonyl)-L-proly...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.33E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Elongin-B/Elongin-C [17-112]/von Hippel-Lindau disease tumor suppressor [55-213] (Homo sapiens (Human)) | BDBM536218 (US11242344, Example 107.2 | US11242344, Example 10...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.41E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The binding of test compounds to the VHL Elongin B/C complex was measured using a fluorescence polarization tracer competition assay. The VHL/Elongin... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536215 ((2R)-1-((2S,4R)-4-hydroxy-2-(5-methyl-5-phenyl-4,5...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.45E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536264 (1-((2S,4R)-2-(1-ethyl-5,5-dimethyl-4,5-dihydro-1H-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.57E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
von Hippel-Lindau disease tumor suppressor (Homo sapiens (Human)) | BDBM536232 ((5S)-2-((4R)-4-Hydroxy-1-(3-methyl-2-(1-methyl-1H-...) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.81E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The VHL NanoBRET™ Target Engagement Assay analyzes the apparent affinity of test compounds for VHL in cells by competitive displacement of a VHL Nano... | Citation and Details BindingDB Entry DOI: 10.7270/Q2KW5K7X | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 318 total ) | Next | Last >> |